- Advertisement -

NIH, Gates Foundation Commit $200M to HIV, Sickle Cell Gene Therapies

NIH Director Francis S. Collins, MD, PhD. The NIH and the Bill and Melinda Gates Foundation said they are committing a total $200 million toward...

Orally Administered Robotic Drug Delivery Capsule Tunnels Through Mucus to Deliver Insulin

One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier that lines...

The Navy and Navajo Nation: Foundations for a research relationship

Credit: (U.S. Navy photo by Warren Duffie Jr.) ARLINGTON, Va.–The Department of the Navy’s Historically Black Colleges and Universities/Minority Institutions (HBCU/MI) program recently held its...

Uncovering anxiety: Scientists identify causative pathway and potential cures

Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals. Understanding the neural circuits and molecular...

Novartis Commits up to $2.2B Toward Developing Arrowhead siRNA Therapy

Novartis has agreed to license and develop Arrowhead Pharmaceuticals’ preclinical stage small interfering RNA (siRNA) therapy ARO-SNCA, a potential treatment for Parkinson’s disease and...

CRISPR Gene Editing Critical to Delivering Off-the-Shelf Cell Therapy

The future of cell therapies should be in off-the-shelf products using multiplex gene editing during the manufacturing process. That’s according to Rachel Haurwitz, PhD,...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase III Trial

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

more new items

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

The Emerging Power of Mass Spectrometry in Oncology

Globally, the incidence of newly diagnosed cancer cases is projected to increase over the next decade.1 Despite advancements in personalized medicine and therapeutic options,...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...